KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Accumulated Expenses (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Accumulated Expenses data on record, last reported at $1.4 billion in Q3 2025.

  • For Q3 2025, Accumulated Expenses fell 20.13% year-over-year to $1.4 billion; the TTM value through Sep 2025 reached $1.4 billion, down 20.13%, while the annual FY2024 figure was $1.3 billion, 49.74% up from the prior year.
  • Accumulated Expenses reached $1.4 billion in Q3 2025 per EW's latest filing, up from $1.2 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.7 billion in Q3 2024 and bottomed at $739.5 million in Q3 2022.
  • Average Accumulated Expenses over 5 years is $999.7 million, with a median of $876.1 million recorded in 2023.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 70.44% in 2024, then decreased 20.13% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $802.3 million in 2021, then fell by 0.91% to $795.0 million in 2022, then grew by 7.72% to $856.4 million in 2023, then surged by 49.74% to $1.3 billion in 2024, then grew by 8.69% to $1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $1.4 billion in Q3 2025, $1.2 billion in Q2 2025, and $1.2 billion in Q1 2025.